Longeveron raises $9.0M via registered direct offering of 2.24M shares at $4.025; warrants at $3.90

Longeveron Inc.

Gross proceeds of approximately $9.0M from sale of 2,236,026 shares and concurrent private placement of warrants for 2,236,026 shares.
Warrants exercisable immediately at $3.90 per share for 24 months; placement agent fees of 7% plus warrants at $5.0313.
Net proceeds to fund Lomecel-B clinical programs for HLHS and Alzheimer's disease, regulatory approvals, and working capital.
Closing expected on July 19, 2024; H.C. Wainwright acted as exclusive placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.